• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国 COVID-19 患者致命不良结局的临床过程和危险因素:一项全国性回顾性队列研究。

Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea: a nationwide retrospective cohort study.

机构信息

Department of Emergency Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.

Division of Infectious Diseases, Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Republic of Korea.

出版信息

Sci Rep. 2021 May 12;11(1):10066. doi: 10.1038/s41598-021-89548-y.

DOI:10.1038/s41598-021-89548-y
PMID:33980912
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8115137/
Abstract

We investigated association between epidemiological and clinical characteristics of coronavirus disease 2019 (COVID-19) patients and clinical outcomes in Korea. This nationwide retrospective cohort study included 5621 discharged patients with COVID-19, extracted from the Korea Disease Control and Prevention Agency (KDCA) database. We compared clinical data between survivors (n = 5387) and non-survivors (n = 234). We used logistic regression analysis and Cox proportional hazards model to explore risk factors of death and fatal adverse outcomes. Increased odds ratio (OR) of mortality occurred with age (≥ 60 years) [OR 11.685, 95% confidence interval (CI) 4.655-34.150, p < 0.001], isolation period, dyspnoea, altered mentality, diabetes, malignancy, dementia, and intensive care unit (ICU) admission. The multivariable regression equation including all potential variables predicted mortality (AUC = 0.979, 95% CI 0.964-0.993). Cox proportional hazards model showed increasing hazard ratio (HR) of mortality with dementia (HR 6.376, 95% CI 3.736-10.802, p < 0.001), ICU admission (HR 4.233, 95% CI 2.661-6.734, p < 0.001), age ≥ 60 years (HR 3.530, 95% CI 1.664-7.485, p = 0.001), malignancy (HR 3.054, 95% CI 1.494-6.245, p = 0.002), and dyspnoea (HR 1.823, 95% CI 1.125-2.954, p = 0.015). Presence of dementia, ICU admission, age ≥ 60 years, malignancy, and dyspnoea could help clinicians identify COVID-19 patients with poor prognosis.

摘要

我们研究了 2019 年冠状病毒病 (COVID-19) 患者的流行病学和临床特征与临床结局之间的关系,并在韩国进行了全国性回顾性队列研究。本研究从韩国疾病控制与预防署 (KDCA) 数据库中提取了 5621 名出院的 COVID-19 患者,将其作为研究对象。我们比较了幸存者(n=5387)和非幸存者(n=234)的临床数据。我们使用逻辑回归分析和 Cox 比例风险模型来探讨死亡和致命不良结局的危险因素。死亡率的优势比(OR)随着年龄(≥60 岁)[OR 11.685,95%置信区间(CI)4.655-34.150,p<0.001]、隔离期、呼吸困难、意识改变、糖尿病、恶性肿瘤、痴呆和重症监护病房(ICU)入院而增加。包含所有潜在变量的多变量回归方程预测死亡率(AUC=0.979,95%CI 0.964-0.993)。Cox 比例风险模型显示,痴呆(HR 6.376,95%CI 3.736-10.802,p<0.001)、ICU 入院(HR 4.233,95%CI 2.661-6.734,p<0.001)、年龄≥60 岁(HR 3.530,95%CI 1.664-7.485,p=0.001)、恶性肿瘤(HR 3.054,95%CI 1.494-6.245,p=0.002)和呼吸困难(HR 1.823,95%CI 1.125-2.954,p=0.015)的 HR 值增加与死亡率相关。痴呆、ICU 入院、年龄≥60 岁、恶性肿瘤和呼吸困难的存在有助于临床医生识别 COVID-19 预后不良的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/8115137/b3f3bf0e7ef1/41598_2021_89548_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/8115137/5e89c37e2041/41598_2021_89548_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/8115137/4eaadd5dcd1c/41598_2021_89548_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/8115137/b3f3bf0e7ef1/41598_2021_89548_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/8115137/5e89c37e2041/41598_2021_89548_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/8115137/4eaadd5dcd1c/41598_2021_89548_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bd9/8115137/b3f3bf0e7ef1/41598_2021_89548_Fig3_HTML.jpg

相似文献

1
Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea: a nationwide retrospective cohort study.韩国 COVID-19 患者致命不良结局的临床过程和危险因素:一项全国性回顾性队列研究。
Sci Rep. 2021 May 12;11(1):10066. doi: 10.1038/s41598-021-89548-y.
2
Clinical Characteristics and Outcomes of COVID-19 Cohort Patients in Daegu Metropolitan City Outbreak in 2020.2020 年大邱市新冠肺炎暴发期间的新冠肺炎患者临床特征和结局。
J Korean Med Sci. 2021 Jan 4;36(1):e12. doi: 10.3346/jkms.2021.36.e12.
3
Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.中国 COVID-19 不良临床结局的危险因素:一项多中心、回顾性、观察性研究。
Theranostics. 2020 May 15;10(14):6372-6383. doi: 10.7150/thno.46833. eCollection 2020.
4
Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.韩国2019冠状病毒病儿科患者的特征。
J Korean Med Sci. 2021 May 24;36(20):e148. doi: 10.3346/jkms.2021.36.e148.
5
Clinical Outcomes of COVID-19 Patients with Type 2 Diabetes: A Population-Based Study in Korea.韩国基于人群的研究:2 型糖尿病合并 COVID-19 患者的临床结局。
Endocrinol Metab (Seoul). 2020 Dec;35(4):901-908. doi: 10.3803/EnM.2020.787. Epub 2020 Dec 10.
6
Comparative risk of incidence and clinical outcomes of COVID-19 among proton pump inhibitor and histamine-2 receptor antagonist short-term users: a nationwide retrospective cohort study.质子泵抑制剂和组胺 2 受体拮抗剂短期使用者 COVID-19 发病和临床结局的比较风险:一项全国性回顾性队列研究。
BMC Pharmacol Toxicol. 2022 Jan 17;23(1):9. doi: 10.1186/s40360-022-00549-7.
7
Age-adjusted Charlson comorbidity index score is the best predictor for severe clinical outcome in the hospitalized patients with COVID-19 infection.年龄调整 Charlson 共病指数评分是预测 COVID-19 感染住院患者严重临床结局的最佳指标。
Medicine (Baltimore). 2021 May 7;100(18):e25900. doi: 10.1097/MD.0000000000025900.
8
Characteristics and prognostic factors of COVID-19 among infected cases: a nationwide Tunisian analysis.新冠病毒感染病例的特征和预后因素:一项全国性的突尼斯分析。
BMC Infect Dis. 2021 Feb 3;21(1):140. doi: 10.1186/s12879-021-05844-y.
9
Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.中国武汉 COVID-19 合并糖尿病患者的临床特征和死亡危险因素:一项两中心回顾性研究。
Diabetes Care. 2020 Jul;43(7):1382-1391. doi: 10.2337/dc20-0598. Epub 2020 May 14.
10
Prognostic Factors for Severe Coronavirus Disease 2019 in Daegu, Korea.韩国大邱严重冠状病毒病 2019 的预后因素。
J Korean Med Sci. 2020 Jun 15;35(23):e209. doi: 10.3346/jkms.2020.35.e209.

引用本文的文献

1
Retrospective Evaluation of the Efficacy of Combined Antiviral Therapy Versus Monotherapy in High-Risk Hospitalized COVID-19 Patients.高危住院COVID-19患者联合抗病毒治疗与单一疗法疗效的回顾性评估
Cureus. 2025 Apr 8;17(4):e81903. doi: 10.7759/cureus.81903. eCollection 2025 Apr.
2
Cardiovascular Outcomes in Hospitalized Patients with COVID-19: Does Age Really Matter?新冠肺炎住院患者的心血管结局:年龄真的重要吗?
J Cardiovasc Dev Dis. 2025 Jan 24;12(2):41. doi: 10.3390/jcdd12020041.
3
Single nucleotide variants in the , and genes and their association with the severity of COVID-19 in an Ecuadorian population.

本文引用的文献

1
Statin and outcomes of coronavirus disease 2019 (COVID-19): A systematic review, meta-analysis, and meta-regression.他汀类药物与 2019 冠状病毒病(COVID-19)结局的关系:系统评价、荟萃分析和荟萃回归。
Nutr Metab Cardiovasc Dis. 2021 Jun 7;31(6):1662-1670. doi: 10.1016/j.numecd.2021.02.020. Epub 2021 Feb 27.
2
Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis.炎症和血液学标志物作为 COVID-19 感染严重结局的预测因子:系统评价和荟萃分析。
Am J Emerg Med. 2021 Mar;41:110-119. doi: 10.1016/j.ajem.2020.12.076. Epub 2020 Dec 30.
3
A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs.
、 和 基因中的单核苷酸变异与厄瓜多尔人群 COVID-19 严重程度的关联。
Front Cell Infect Microbiol. 2024 Apr 17;14:1322882. doi: 10.3389/fcimb.2024.1322882. eCollection 2024.
4
Factors related to lung function outcomes in critically ill COVID-19 patients in South Korea.韩国重症 COVID-19 患者肺功能预后的相关因素。
Acute Crit Care. 2024 Feb;39(1):100-107. doi: 10.4266/acc.2023.00668. Epub 2024 Feb 20.
5
COVID-19 Vaccination and Clinical Outcomes at a Secondary Referral Hospital During the Delta Variant-dominant Period in West Sumatra, Indonesia.印度尼西亚西苏门答腊省德尔塔变异株流行期间二级转诊医院的 COVID-19 疫苗接种和临床结局。
J Prev Med Public Health. 2023 May;56(3):221-230. doi: 10.3961/jpmph.23.077. Epub 2023 May 31.
6
COVID-19 Chest CT Quantification: Triage and Prognostic Value in Different Ages.COVID-19 胸部 CT 量化:不同年龄段的分诊和预后价值。
Clin Med Res. 2023 Mar;21(1):14-25. doi: 10.3121/cmr.2023.1772.
7
Negative Conversion of Polymerase Chain Reaction and Clinical Outcomes according to the SARS-CoV-2 Variant in Critically Ill Patients with COVID-19.新型冠状病毒肺炎重症患者中聚合酶链反应的阴性转化及根据严重急性呼吸综合征冠状病毒2变异株的临床结局
Tuberc Respir Dis (Seoul). 2023 Apr;86(2):142-149. doi: 10.4046/trd.2022.0151. Epub 2023 Mar 16.
8
An algorithm to predict the need for invasive mechanical ventilation in hospitalized COVID-19 patients: the experience in Sao Paulo.一种预测住院COVID-19患者有创机械通气需求的算法:圣保罗的经验。
Acute Crit Care. 2022 Nov;37(4):580-591. doi: 10.4266/acc.2022.00283. Epub 2022 Sep 8.
9
Risk factors for hospitalization and death due to COVID-19 among frail community-dwelling elderly people: a retrospective cohort study.衰弱的社区居住老年人因 COVID-19 住院和死亡的危险因素:一项回顾性队列研究。
Sao Paulo Med J. 2022 Sep-Oct;140(5):676-681. doi: 10.1590/1516-3180.2021.0649.R1.20122021.
10
A retrospective cohort study on COVID-19 at 2 Los Angeles hospitals: Older age, low triage oxygenation, and chronic kidney disease among the top risk factors associated with in-hospital mortality.洛杉矶 2 家医院 COVID-19 的回顾性队列研究:高龄、分诊时低氧合、慢性肾脏病是与院内死亡率相关的最高风险因素。
PLoS One. 2022 Jun 22;17(6):e0268688. doi: 10.1371/journal.pone.0268688. eCollection 2022.
2019年冠状病毒病(COVID-19)的治疗综述:药物重新利用与未满足的临床需求
Front Pharmacol. 2020 Nov 17;11:584956. doi: 10.3389/fphar.2020.584956. eCollection 2020.
4
Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study.比较 COVID-19 和季节性流感的特征、发病率和死亡率:一项全国性、基于人群的回顾性队列研究。
Lancet Respir Med. 2021 Mar;9(3):251-259. doi: 10.1016/S2213-2600(20)30527-0. Epub 2020 Dec 17.
5
Impact of Hospital Bed Shortages on the Containment of COVID-19 in Wuhan.医院床位短缺对武汉 COVID-19 疫情控制的影响。
Int J Environ Res Public Health. 2020 Nov 18;17(22):8560. doi: 10.3390/ijerph17228560.
6
Machine learning prediction for mortality of patients diagnosed with COVID-19: a nationwide Korean cohort study.基于全国韩国队列研究的 COVID-19 患者死亡率的机器学习预测。
Sci Rep. 2020 Oct 30;10(1):18716. doi: 10.1038/s41598-020-75767-2.
7
The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19.合并症和治疗干预对 COVID-19 的影响。
Front Immunol. 2020 Aug 11;11:1991. doi: 10.3389/fimmu.2020.01991. eCollection 2020.
8
Metformin use is associated with reduced mortality rate from coronavirus disease 2019 (COVID-19) infection.使用二甲双胍与降低2019冠状病毒病(COVID-19)感染的死亡率相关。
Obes Med. 2020 Sep;19:100290. doi: 10.1016/j.obmed.2020.100290. Epub 2020 Aug 18.
9
Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study.德国 1904 例 COVID-19 住院患者的临床病程和结局相关因素:一项观察性研究。
Clin Microbiol Infect. 2020 Dec;26(12):1663-1669. doi: 10.1016/j.cmi.2020.08.011. Epub 2020 Aug 18.
10
Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.COVID-19 感染患者血液学和免疫学标志物的诊断和预后价值:6320 例患者的荟萃分析。
PLoS One. 2020 Aug 21;15(8):e0238160. doi: 10.1371/journal.pone.0238160. eCollection 2020.